サマリー

欧州と北米のデジタル治療器（DTx）市場は、2023年から2030年の予測期間において、欧州で23.53％、北米で24.8％の大幅なCAGRを記録すると予測されます。この新しい市場レポートは、歴史的な年2021年のデータを含み、計算の基準年は2022年で、予測期間は2023年から2030年です
市場セグメンテーションを行います：
欧州・北米のデジタル治療器（DTx）市場、製品タイプ別（ハードウェア製品、ソリューション/ソフトウェア、サービス）、用途別（治療/ケア関連用途、予防用途）、購入形態別（団体購入組織、個人）、販売チャネル別（B2B、B2C）、国別（米国、カナダ、メキシコ、ドイツ、英国、フランス、イタリア、スペイン、オランダ、ロシア、スイス、トルコ、ベルギー、その他欧州） - 産業動向と2030年予測。


欧州・北米のデジタルセラピー（DTx）市場の成長に寄与する主な要因としては、以下のようなものが挙げられます：
- 政府機関による認知度の向上。
- スマートフォン利用者の増加
市場プレイヤー

欧州と北米のデジタル治療器（DTx）市場で活動している主要な市場プレイヤーを以下に紹介します：
- Noom
- アテンティブ
- コグノア
- カイアヘルス
- ジンジャー
- リボンゴヘルス
- マンゴー健康法
- 自然のサイクル
- コグニフィット
- フィットビット社（Fitbit, Inc.
- オマダヘルス
- プロペラヘルス
- ウェルドック株式会社
- スマートペイシェントGMBH
- マインドストロング・ヘルス
- アヨゴヘルス
- より良い治療法
- トゥーモロー
- カナリアヘルス
- クリックセラピューティクス
- ペア・セラピューティクス
- ボランチ
- アキリ・インタラクティブ・ラボ
- サムスン
- レスメド
- GAIA AG

ページTOPに戻る

目次

TABLE OF CONTENTS
1 INTRODUCTION 27
1.1 OBJECTIVES OF THE STUDY 27
1.2 MARKET DEFINITION 27
1.3 OVERVIEW OF EUROPE AND NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET 27
1.4 LIMITATIONS 29
1.5 MARKETS COVERED 29
2 MARKET SEGMENTATION 31
2.1 MARKETS COVERED 31
2.2 GEOGRAPHICAL SCOPE 32
2.3 YEARS CONSIDERED FOR THE STUDY 32
2.4 CURRENCY AND PRICING 32
2.5 DBMR TRIPOD DATA VALIDATION MODEL 33
2.6 MULTIVARIATE MODELLING 37
2.7 PRODUCT AND SERVICE TYPE LIFELINE CURVE 38
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 39
2.9 DBMR MARKET POSITION GRID 40
2.10 MARKET APPLICATION COVERAGE GRID 41
2.11 VENDOR SHARE ANALYSIS 43
2.12 SECONDARY SOURCES 44
2.13 ASSUMPTIONS 44
3 EXECUTIVE SUMMARY 45
4 PREMIUM INSIGHT 48
4.1 PESTEL ANALYSIS 50
4.2 PORTER’S FIVE FORCES 51
5 EUROPE AND NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET, INDUSTRY INSIGHT 52
CONCLUSION: 53
6 EUROPE AND NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET, REGULATION 54
7 MARKET OVERVIEW 58
7.1 DRIVERS 60
7.1.1 RISE IN THE PREVALENCE OF CHRONIC DISEASES 60
7.1.2 INCREASE IN AWARENESS BY GOVERNMENT AGENCIES 60
7.1.3 TECHNOLOGICAL ADVANCEMENT IN HEALTHCARE 60
7.1.4 INCREASED NUMBER OF PEOPLE USING SMARTPHONES 61
7.1.5 IMPROVED QUALITY OF LIFE 61
7.2 RESTRAINTS 62
7.2.1 PATIENT INFORMATION PRIVACY POLICIES 62
7.2.2 DIGITAL PAYMENT ASSOCIATED WITH DIGITAL THERAPEUTICS 62
7.2.3 UNDERDEVELOPED COUNTRIES LACKING SMARTPHONES AND INTERNET FACILITIES 63
7.3 OPPORTUNITIES 63
7.3.1 RISING DEMAND FOR DIGITAL THERAPEUTICS 63
7.3.2 COLLABORATION BETWEEN COMPANIES TO PROVIDE BETTER PRODUCTS/SERVICES 63
7.3.3 PARTNERSHIP BETWEEN COMPANIES 64
7.3.4 EXPANSION AND LAUNCH OF PRODUCTS 64
7.3.5 EVENTS AND EXHIBITION 65
7.3.6 PHYSICIAN ADOPTION 65
7.4 CHALLENGES 66
7.4.1 CLINICAL VALIDATION 66
7.4.2 REGULATORY APPROVAL 66
7.4.3 PAYER REIMBURSEMENT 66
8 EUROPE AND NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET, BY PRODUCT AND SERVICE TYPE 68
8.1 OVERVIEW 69
8.2 SOLUTIONS/SOFTWARE 76
8.3 HARDWARE PRODUCTS 76
8.4 SERVICE 77
9 EUROPE AND NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION 78
9.1 OVERVIEW 79
9.2 TREATMENT/CARE-RELATED APPLICATIONS 85
9.2.1 DIABETIS 87
9.2.1.1 TYPE 2 87
9.2.1.2 TYPE 1 87
9.2.2 CENTRAL NERVOUS SYSTEM DISORDERS 88
9.2.2.1 MENTAL HEALTH DISORDER 88
9.2.2.2 OTHER CNS DISORDERS 88
9.2.3 SMOKING CESSATION 89
9.2.4 CHRONIC RESPIRATORY DISEASES 89
9.2.4.1 ASTHMA 89
9.2.4.2 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 90
9.2.4.3 OTHERS 90
9.2.5 CARDIOVASCULAR DISEASES 90
9.2.5.1 ARRHYTMIA 91
9.2.5.2 HEART FAILURE 91
9.2.5.3 OTHERS 91
9.2.6 MEDICATION ADHERENCE 91
9.2.7 ONCOLOGY 91
9.2.8 GASTROINTESTINAL DISORDERS 91
9.2.9 REHABILITATION & PATIENT CARE 92
9.2.10 SUBSTANCE USE DISORDERS & ADDICTION MANAGEMENT 92
9.2.11 OTHER TREATMENT/CARE-RELATED APPLICATIONS 92
9.3 PREVENTIVE APPLICATION 92
9.3.1 HEART ATTACKS 93
9.3.2 PREDIABETES 94
9.3.3 OBESITY 94
9.3.4 NUTRITION 94
9.3.5 LIFESTYLE MANAGEMENT 94
9.3.6 OTHER PREVENTIVE APPLICATIONS 94
10 EUROPE AND NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE 95
10.1 OVERVIEW 96
10.2 GROUP PURCHASE ORGANIZATION 102
10.3 SOLUTIONS/SOFTWARE 103
10.4 HARDWARE PRODUCTS 103
10.5 SERVICE 103
10.6 INDIVIDUAL 104
10.6.1 SOLUTIONS/SOFTWARE 105
10.6.2 HARDWARE PRODUCTS 105
10.6.3 SERVICE 105
11 EUROPE AND NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL 106
11.1 OVERVIEW 107
11.2 B2B 113
11.2.1 PAYERS 114
11.2.2 EMPLOYERS 114
11.2.3 PHARMACEUTICAL COMPANIES 115
11.2.4 PROVIDERS 115
11.2.5 OTHER BUYERS 115
11.3 B2C 115
11.3.1 CAREGIVERS 116
11.3.2 PATIENTS 116
12 EUROPE AND NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET 117
12.1 NORTH AMERICA 117
12.1.1 U.S. 122
12.1.2 CANADA 126
12.1.3 MEXICO 130
12.2 EUROPE 134
12.2.1 GERMANY 139
12.2.2 FRANCE 144
12.2.3 ITALY 148
12.2.4 U.K. 152
12.2.5 SPAIN 156
12.2.6 SWITZERLAND 160
12.2.7 IRELAND 165
12.2.8 NETHERLANDS 170
12.2.9 RUSSIA 175
12.2.10 HUNGARY 180
12.2.11 TURKEY 185
12.2.12 AUSTRIA 190
12.2.13 POLAND 195
12.2.14 NORWAY 200
12.2.15 LITHUANIA 204
12.2.16 REST OF EUROPE 209
13 EUROPE AND NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET, COMPANY LANDSCAPE 210
13.1 COMPANY SHARE ANALYSIS: NORTH AMERICA 210
13.2 COMPANY SHARE ANALYSIS: EUROPE 211
14 SWOT ANALYSIS 212
15 COMPANY PROFILE 213
15.1 SAMSUNG 213
15.1.1 COMPANY SNAPSHOT 213
15.1.2 REVENUE ANALYSIS 214
15.1.3 PRODUCT PORTFOLIO 214
15.1.4 RECENT DEVELOPMENT 214
15.2 VOLUNTIS 215
15.2.1 COMPANY SNAPSHOT 215
15.2.2 REVENUE ANALYSIS 215
15.2.3 PRODUCT PORTFOLIO 216
15.2.4 RECENT DEVELOPMENT 216
15.3 NOOM, INC. 217
15.3.1 COMPANY SNAPSHOT 217
15.3.2 PRODUCT PORTFOLIO 217
15.3.3 RECENT DEVELOPMENT 217
15.4 FITBIT, INC. 218
15.4.1 COMPANY SNAPSHOT 218
15.4.2 PRODUCT PORTFOLIO 218
15.4.3 RECENT DEVELOPMENTS 218
15.5 LIVONGO 220
15.5.1 COMPANY SNAPSHOT 220
15.5.2 REVENUE ANALYSIS 220
15.5.3 PRODUCT PORTFOLIO 221
15.5.4 RECENT DEVELOPMENT 221
15.6 AKILI INTERACTIVE LABS, INC. 222
15.6.1 COMPANY SNAPSHOT 222
15.6.2 REVENUE ANALYSIS 222
15.6.3 PRODUCT PORTFOLIO 223
15.6.4 RECENT DEVELOPMENTS 223
15.7 ATENTIV 224
15.7.1 COMPANY SNAPSHOT 224
15.7.2 PRODUCT PORTFOLIO 224
15.7.3 RECENT DEVELOPMENTS 224
15.8 AYOGO HEALTH INC. 225
15.8.1 COMPANY SNAPSHOT 225
15.8.2 PRODUCT PORTFOLIO 225
15.8.3 RECENT DEVELOPMENT 225
15.9 BETTER THERAPEUTICS, INC 226
15.9.1 COMPANY SNAPSHOT 226
15.9.2 PRODUCT PORTFOLIO 226
15.9.3 RECENT DEVELOPMENTS 226
15.10 CANARY HEALTH 228
15.10.1 COMPANY SNAPSHOT 228
15.10.2 PRODUCT PORTFOLIO 228
15.10.3 RECENT DEVELOPMENT 228
15.11 COGNOA 229
15.11.1 COMPANY SNAPSHOT 229
15.11.2 PRODUCT PORTFOLIO 229
15.11.3 RECENT DEVELOPMENTS 229
15.12 COGNIFIT 230
15.12.1 COMPANY SNAPSHOT 230
15.12.2 PRODUCT PORTFOLIO 230
15.12.3 RECENT DEVELOPMENT 230
15.13 CLICK THERAPEUTICS, INC. 231
15.13.1 COMPANY SNAPSHOT 231
15.13.2 PRODUCT PORTFOLIO 231
15.13.3 RECENT DEVELOPMENT 232
15.14 GINGER 233
15.14.1 COMPANY SNAPSHOT 233
15.14.2 PRODUCT PORTFOLIO 233
15.14.3 RECENT DEVELOPMENT 233
15.15 GAIA AG 234
15.15.1 COMPANY SNAPSHOT 234
15.15.2 PRODUCT PORTFOLIO 234
15.15.3 RECENT DEVELOPMENT 234
15.16 KAIA HEALTH 235
15.16.1 COMPANY SNAPSHOT 235
15.16.2 PRODUCT PORTFOLIO 235
15.16.3 RECENT DEVELOPMENTS 235
15.17 MANGO HEALTH 236
15.17.1 COMPANY SNAPSHOT 236
15.17.2 PRODUCT PORTFOLIO 236
15.17.3 RECENT DEVELOPMENT 236
15.18 MINDSTRONG HEALTH 237
15.18.1 COMPANY SNAPSHOT 237
15.18.2 PRODUCT PORTFOLIO 237
15.18.3 RECENT DEVELOPMENT 237
15.19 2MORROW INC. 238
15.19.1 COMPANY SNAPSHOT 238
15.19.2 PRODUCT PORTFOLIO 238
15.19.3 RECENT DEVELOPMENTS 238
15.20 NATURAL CYCLES USA CORP 240
15.20.1 COMPANY SNAPSHOT 240
15.20.2 PRODUCT PORTFOLIO 240
15.20.3 RECENT DEVELOPMENT 240
15.21 OMADA HEALTH, INC. 241
15.21.1 COMPANY SNAPSHOT 241
15.21.2 PRODUCT PORTFOLIO 241
15.21.3 RECENT DEVELOPMENTS 241
15.22 PEAR THERAPEUTICS, INC. 242
15.22.1 COMPANY SNAPSHOT 242
15.22.2 PRODUCT PORTFOLIO 242
15.22.3 RECENT DEVELOPMENT 242
15.23 RESMED 243
15.23.1 COMPANY SNAPSHOT 243
15.23.2 REVENUE ANALYSIS 243
15.23.3 PRODUCT PORTFOLIO 244
15.23.4 RECENT DEVELOPMENT 244
15.24 SMARTPATIENT GMBH 245
15.24.1 COMPANY SNAPSHOT 245
15.24.2 PRODUCT PORTFOLIO 245
15.24.3 RECENT DEVELOPMENT 245
15.25 WELLDOC, INC. 246
15.25.1 COMPANY SNAPSHOT 246
15.25.2 PRODUCT PORTFOLIO 246
15.25.3 RECENT DEVELOPMENTS 246
16 QUESTIONNAIRE 247
17 RELATED REPORTS 250

ページTOPに戻る

図表リスト

LIST OF TABLES
TABLE 1 REGULATORY FRAMEWORK 54
TABLE 2 EUROPE DIGITAL THERAPEUTIC (DTX) MARKET, BY PRODUCT AND SERVICE TYPE, 2021-2030 (USD MILLION) 75
TABLE 3 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET, BY PRODUCT AND SERVICE TYPE, 2021-2030 (USD MILLION) 75
TABLE 4 EUROPE DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 85
TABLE 5 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 85
TABLE 6 EUROPE TREATMENT/CARE-RELATED APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 86
TABLE 7 NORTH AMERICA TREATMENT/CARE-RELATED APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 86
TABLE 8 EUROPE DIABETES IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 87
TABLE 9 NORTH AMERICA DIABETES IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 87
TABLE 10 EUROPE CENTRAL NERVOUS SYSTEM DISORDERS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 88
TABLE 11 NORTH AMERICA CENTRAL NERVOUS SYSTEM DISORDERS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 88
TABLE 12 EUROPE CHRONIC RESPIRATORY DISEASES IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 89
TABLE 13 NORTH AMERICA CHRONIC RESPIRATORY DISEASES IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 89
TABLE 14 EUROPE CARDIOVASCULAR DISEASES IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 90
TABLE 15 NORTH AMERICA CARDIOVASCULAR DISEASES IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 91
TABLE 16 EUROPE PREVENTIVE APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 93
TABLE 17 NORTH AMERICA PREVENTIVE APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 93
TABLE 18 EUROPE DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2021-2030 (USD MILLION) 102
TABLE 19 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2021-2030 (USD MILLION) 102
TABLE 20 EUROPE GROUP PURCHASE ORGANIZATION IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2021-2030 (USD MILLION) 103
TABLE 21 NORTH AMERICA GROUP PURCHASE ORGANIZATION IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2021-2030 (USD MILLION) 103
TABLE 22 EUROPE INDIVIDUAL IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2021-2030 (USD MILLION) 104
TABLE 23 NORTH AMERICA INDIVIDUAL IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2021-2030 (USD MILLION) 104
TABLE 24 EUROPE DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2021-2030 (USD MILLION) 113
TABLE 25 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2021-2030 (USD MILLION) 113
TABLE 26 EUROPE B2B IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2021-2030 (USD MILLION) 114
TABLE 27 NORTH AMERICA B2B IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2021-2030 (USD MILLION) 114
TABLE 28 EUROPE B2C IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2021-2030 (USD MILLION) 116
TABLE 29 NORTH AMERICA B2C IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2021-2030 (USD MILLION) 116
TABLE 30 NORTH AMERICA DIGITAL THERAPEUTIC (DTX) MARKET, BY COUNTRY, 2021-2030 (USD MILLION) 121
TABLE 31 U.S. DIGITAL THERAPEUTIC (DTX) MARKET, BY PRODUCT AND SERVICE TYPE, 2021-2030 (USD MILLION) 122
TABLE 32 U.S. DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 122
TABLE 33 U.S. TREATMENT/CARE-RELATED APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 122
TABLE 34 U.S. CENTRAL NERVOUS SYSTEM DISORDERS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 123
TABLE 35 U.S. CARDIOVASCULAR DISEASES IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 123
TABLE 36 U.S. CHRONIC RESPIRATORY DISEASES IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 123
TABLE 37 U.S. DIABETES IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 123
TABLE 38 U.S. PREVENTIVE APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 124
TABLE 39 U.S. DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2021-2030 (USD MILLION) 124
TABLE 40 U.S. GROUP PURCHASE ORGANIZATION IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2021-2030 (USD MILLION) 124
TABLE 41 U.S. INDIVIDUAL IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2021-2030 (USD MILLION) 124
TABLE 42 U.S. DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2021-2030 (USD MILLION) 125
TABLE 43 U.S. B2B IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2021-2030 (USD MILLION) 125
TABLE 44 U.S. B2C IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2021-2030 (USD MILLION) 125
TABLE 45 CANADA DIGITAL THERAPEUTIC (DTX) MARKET, BY PRODUCT AND SERVICE TYPE, 2021-2030 (USD MILLION) 126
TABLE 46 CANADA DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 126
TABLE 47 CANADA TREATMENT/CARE-RELATED APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 126
TABLE 48 CANADA CENTRAL NERVOUS SYSTEM DISORDERS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 127
TABLE 49 CANADA CARDIOVASCULAR DISEASES IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 127
TABLE 50 CANADA CHRONIC RESPIRATORY DISEASES IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 127
TABLE 51 CANADA DIABETES IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 127
TABLE 52 CANADA PREVENTIVE APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 128
TABLE 53 CANADA DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2021-2030 (USD MILLION) 128
TABLE 54 CANADA GROUP PURCHASE ORGANIZATION IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2021-2030 (USD MILLION) 128
TABLE 55 CANADA INDIVIDUAL IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2021-2030 (USD MILLION) 129
TABLE 56 CANADA DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2021-2030 (USD MILLION) 129
TABLE 57 CANADA B2B IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2021-2030 (USD MILLION) 129
TABLE 58 CANADA B2C IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2021-2030 (USD MILLION) 129
TABLE 59 MEXICO DIGITAL THERAPEUTIC (DTX) MARKET, BY PRODUCT AND SERVICE TYPE, 2021-2030 (USD MILLION) 130
TABLE 60 MEXICO DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 130
TABLE 61 MEXICO TREATMENT/CARE-RELATED APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 130
TABLE 62 MEXICO CENTRAL NERVOUS SYSTEM DISORDERS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 131
TABLE 63 MEXICO CARDIOVASCULAR DISEASES IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 131
TABLE 64 MEXICO CHRONIC RESPIRATORY DISEASES IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 131
TABLE 65 MEXICO DIABETES IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 131
TABLE 66 MEXICO PREVENTIVE APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 132
TABLE 67 MEXICO DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2021-2030 (USD MILLION) 132
TABLE 68 MEXICO GROUP PURCHASE ORGANIZATION IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2021-2030 (USD MILLION) 132
TABLE 69 MEXICO INDIVIDUAL IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2021-2030 (USD MILLION) 132
TABLE 70 MEXICO DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2021-2030 (USD MILLION) 133
TABLE 71 MEXICO B2B IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2021-2030 (USD MILLION) 133
TABLE 72 MEXICO B2C IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2021-2030 (USD MILLION) 133
TABLE 73 EUROPE DIGITAL THERAPEUTIC (DTX) MARKET, BY COUNTRY, 2021-2030 (USD MILLION) 138
TABLE 74 GERMANY DIGITAL THERAPEUTIC (DTX) MARKET, BY PRODUCT AND SERVICE TYPE, 2021-2030 (USD MILLION) 139
TABLE 75 GERMANY DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 139
TABLE 76 GERMANY TREATMENT/CARE-RELATED APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 140
TABLE 77 GERMANY CENTRAL NERVOUS SYSTEM DISORDERS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 140
TABLE 78 GERMANY CARDIOVASCULAR DISEASES IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 141
TABLE 79 GERMANY CHRONIC RESPIRATORY DISEASES IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 141
TABLE 80 GERMANY DIABETES IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 141
TABLE 81 GERMANY PREVENTIVE APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 142
TABLE 82 GERMANY DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2021-2030 (USD MILLION) 142
TABLE 83 GERMANY GROUP PURCHASE ORGANIZATION IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2021-2030 (USD MILLION) 142
TABLE 84 GERMANY INDIVIDUAL IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2021-2030 (USD MILLION) 143
TABLE 85 GERMANY DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2021-2030 (USD MILLION) 143
TABLE 86 GERMANY B2B IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2021-2030 (USD MILLION) 143
TABLE 87 GERMANY B2C IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2021-2030 (USD MILLION) 143
TABLE 88 FRANCE DIGITAL THERAPEUTIC (DTX) MARKET, BY PRODUCT AND SERVICE TYPE, 2021-2030 (USD MILLION) 144
TABLE 89 FRANCE DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 144
TABLE 90 FRANCE TREATMENT/CARE-RELATED APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 144
TABLE 91 FRANCE CENTRAL NERVOUS SYSTEM DISORDERS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 145
TABLE 92 FRANCE CARDIOVASCULAR DISEASES IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 145
TABLE 93 FRANCE CHRONIC RESPIRATORY DISEASES IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 145
TABLE 94 FRANCE DIABETES IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 145
TABLE 95 FRANCE PREVENTIVE APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 146
TABLE 96 FRANCE DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2021-2030 (USD MILLION) 146
TABLE 97 FRANCE GROUP PURCHASE ORGANIZATION IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2021-2030 (USD MILLION) 146
TABLE 98 FRANCE INDIVIDUAL IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2021-2030 (USD MILLION) 147
TABLE 99 FRANCE DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2021-2030 (USD MILLION) 147
TABLE 100 FRANCE B2B IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2021-2030 (USD MILLION) 147
TABLE 101 FRANCE B2C IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2021-2030 (USD MILLION) 147
TABLE 102 ITALY DIGITAL THERAPEUTIC (DTX) MARKET, BY PRODUCT AND SERVICE TYPE, 2021-2030 (USD MILLION) 148
TABLE 103 ITALY DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 148
TABLE 104 ITALY TREATMENT/CARE-RELATED APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 148
TABLE 105 ITALY CENTRAL NERVOUS SYSTEM DISORDERS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 149
TABLE 106 ITALY CARDIOVASCULAR DISEASES IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 149
TABLE 107 ITALY CHRONIC RESPIRATORY DISEASES IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 149
TABLE 108 ITALY DIABETES IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 149
TABLE 109 ITALY PREVENTIVE APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 150
TABLE 110 ITALY DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2021-2030 (USD MILLION) 150
TABLE 111 ITALY GROUP PURCHASE ORGANIZATION IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2021-2030 (USD MILLION) 150
TABLE 112 ITALY INDIVIDUAL IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2021-2030 (USD MILLION) 150
TABLE 113 ITALY DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2021-2030 (USD MILLION) 151
TABLE 114 ITALY B2B IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2021-2030 (USD MILLION) 151
TABLE 115 ITALY B2C IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2021-2030 (USD MILLION) 151
TABLE 116 U.K. DIGITAL THERAPEUTIC (DTX) MARKET, BY PRODUCT AND SERVICE TYPE, 2021-2030 (USD MILLION) 152
TABLE 117 U.K. DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 152
TABLE 118 U.K. TREATMENT/CARE-RELATED APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 152
TABLE 119 U.K. CENTRAL NERVOUS SYSTEM DISORDERS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 153
TABLE 120 U.K. CARDIOVASCULAR DISEASES IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 153
TABLE 121 U.K. CHRONIC RESPIRATORY DISEASES IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 153
TABLE 122 U.K. DIABETES IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 153
TABLE 123 U.K. PREVENTIVE APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 154
TABLE 124 U.K. DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2021-2030 (USD MILLION) 154
TABLE 125 U.K. GROUP PURCHASE ORGANIZATION IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2021-2030 (USD MILLION) 154
TABLE 126 U.K. INDIVIDUAL IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2021-2030 (USD MILLION) 154
TABLE 127 U.K. DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2021-2030 (USD MILLION) 155
TABLE 128 U.K. B2B IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2021-2030 (USD MILLION) 155
TABLE 129 U.K. B2C IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2021-2030 (USD MILLION) 155
TABLE 130 SPAIN DIGITAL THERAPEUTIC (DTX) MARKET, BY PRODUCT AND SERVICE TYPE, 2021-2030 (USD MILLION) 156
TABLE 131 SPAIN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 156
TABLE 132 SPAIN TREATMENT/CARE-RELATED APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 156
TABLE 133 SPAIN CENTRAL NERVOUS SYSTEM DISORDERS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 157
TABLE 134 SPAIN CARDIOVASCULAR DISEASES IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 157
TABLE 135 SPAIN CHRONIC RESPIRATORY DISEASES IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 157
TABLE 136 SPAIN DIABETES IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 157
TABLE 137 SPAIN PREVENTIVE APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 158
TABLE 138 SPAIN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2021-2030 (USD MILLION) 158
TABLE 139 SPAIN GROUP PURCHASE ORGANIZATION IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2021-2030 (USD MILLION) 158
TABLE 140 SPAIN INDIVIDUAL IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2021-2030 (USD MILLION) 158
TABLE 141 SPAIN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2021-2030 (USD MILLION) 159
TABLE 142 SPAIN B2B IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2021-2030 (USD MILLION) 159
TABLE 143 SPAIN B2C IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2021-2030 (USD MILLION) 159
TABLE 144 SWITZERLAND DIGITAL THERAPEUTIC (DTX) MARKET, BY PRODUCT AND SERVICE TYPE, 2021-2030 (USD MILLION) 160
TABLE 145 SWITZERLAND DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 160
TABLE 146 SWITZERLAND TREATMENT/CARE-RELATED APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 161
TABLE 147 SWITZERLAND CENTRAL NERVOUS SYSTEM DISORDERS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 161
TABLE 148 SWITZERLAND CARDIOVASCULAR DISEASES IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 161
TABLE 149 SWITZERLAND CHRONIC RESPIRATORY DISEASES IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 162
TABLE 150 SWITZERLAND DIABETES IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 162
TABLE 151 SWITZERLAND PREVENTIVE APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 162
TABLE 152 SWITZERLAND DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2021-2030 (USD MILLION) 162
TABLE 153 SWITZERLAND GROUP PURCHASE ORGANIZATION IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2021-2030 (USD MILLION) 163
TABLE 154 SWITZERLAND INDIVIDUAL IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2021-2030 (USD MILLION) 163
TABLE 155 SWITZERLAND DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2021-2030 (USD MILLION) 163
TABLE 156 SWITZERLAND B2B IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2021-2030 (USD MILLION) 163
TABLE 157 SWITZERLAND B2C IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2021-2030 (USD MILLION) 164
TABLE 158 IRELAND DIGITAL THERAPEUTIC (DTX) MARKET, BY PRODUCT AND SERVICE TYPE, 2021-2030 (USD MILLION) 165
TABLE 159 IRELAND DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 165
TABLE 160 IRELAND TREATMENT/CARE-RELATED APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 166
TABLE 161 IRELAND CENTRAL NERVOUS SYSTEM DISORDERS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 166
TABLE 162 IRELAND CARDIOVASCULAR DISEASES IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 166
TABLE 163 IRELAND CHRONIC RESPIRATORY DISEASES IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 167
TABLE 164 IRELAND DIABETES IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 167
TABLE 165 IRELAND PREVENTIVE APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 167
TABLE 166 IRELAND DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2021-2030 (USD MILLION) 167
TABLE 167 IRELAND GROUP PURCHASE ORGANIZATION IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2021-2030 (USD MILLION) 168
TABLE 168 IRELAND INDIVIDUAL IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2021-2030 (USD MILLION) 168
TABLE 169 IRELAND DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2021-2030 (USD MILLION) 168
TABLE 170 IRELAND B2B IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2021-2030 (USD MILLION) 168
TABLE 171 IRELAND B2C IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2021-2030 (USD MILLION) 169
TABLE 172 NETHERLANDS DIGITAL THERAPEUTIC (DTX) MARKET, BY PRODUCT AND SERVICE TYPE, 2021-2030 (USD MILLION) 170
TABLE 173 NETHERLANDS DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 170